Search results
GSK’s asthma drug shows promise in reducing severe attacks
WSAU Wausau· 4 days ago(Reuters) - GSK's asthma drug met its primary goal of reducing asthma attacks over a 52-week period...
Asthma Triggers In Homes Can Send Kids to the ER—This Organization Is Working to Change That
Health.com· 4 days agoFor parents of children with asthma, witnessing an attack of severe symptoms can be a terrifying...
GSK Experimental Drug Reduces Severe Asthma Attacks in Key Trial
Bloomberg· 4 days agoAn experimental drug from GSK Plc reduced asthma attacks in late-stage trials, paving the way for a...
GSK's Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows
Benzinga via Yahoo Finance· 4 days agoTuesday, GSK plc (NYSE:GSK) released headline results from the phase III clinical trials SWIFT-1 and...
GSK’s Potential Blockbuster Asthma Drug Shows Promise in Latest Trial
The Wall Street Journal· 4 days agoThe British pharmaceutical company’s depemokimab drug reduced asthma attacks in late-stage trials...
GSK's experimental drug shows promise in reducing severe asthma attacks
Reuters· 4 days ago, opens new tab experimental drug met its primary goal of reducing asthma attacks in a late-stage...
Eosinophilic Asthma
Health via Yahoo News· 6 days agoEosinophils are a type of immune system cell...management techniques are necessary. Targeted therapies, such as biologics, are essential for managing...
Northeast Ohio Black Health Coalition promotes air quality and asthma awareness
WFMJ Youngstown· 15 hours agoThose who suffer from asthma attacks know an attack can be severe, or even fatal. But not everyone...
Manage Your Asthma: FDA on Know Your Triggers and Treatment Options
Sierra Sun Times· 4 days agoAsthma is a chronic lung disease that causes the airways to become inflamed and narrow. Symptoms of...
GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
Zacks via Yahoo Finance· 3 days agoGSK’s GSK two-phase III studies, which evaluated depemokimab for treating severe asthma...
